Chk1 both arrests replication forks and enhances repair of DNA damage by phosphorylating downstream effectors. Although there has been a concerted effort to identify effectors of Chk1 activity, underlying mechanisms of effector action are still being identified. Metnase (also called SETMAR) is a SET and transposase domain protein that promotes both DNA double-strand break (DSB) repair and restart of stalled replication forks. In this study, we show that Metnase is phosphorylated only on Ser495 (S495) in vivo in response to DNA damage by ionizing radiation. Chk1 is the major mediator of this phosphorylation event. We had previously shown that wild-type (wt) Metnase associates with chromatin near DSBs and methylates histone H3 Lys36. Here we show that a Ser495Ala (S495A) Metnase mutant, which is not phosphorylated by Chk1, is defective in DSB-induced chromatin association. The S495A mutant also fails to enhance repair of an induced DSB when compared with wt Metnase. Interestingly, the S495A mutant demonstrated increased restart of stalled replication forks compared with wt Metnase. Thus, phosphorylation of Metnase S495 differentiates between these two functions, enhancing DSB repair and repressing replication fork restart. In summary, these data lend insight into the mechanism by which Chk1 enhances repair of DNA damage while at the same time repressing stalled replication fork restart.
Introduction
Metnase, also known as SETMAR, is a SET (Su(var)3-9, Enhancer-of-zeste, Trithorax) and a transposase fusion protein present only in anthropoid primates (Robertson and Zumpano, 1997; Lee et al., 2005; Cordaux et al., 2006; Jordan, 2006) . The Metnase SET domain dimethylates histone H3 lysine 36 (H3K36me2; Lee et al., 2005) , while the transposase domain has most but not all of the classic transposase nuclease activities, including 5 0 -terminal inverted repeats-specific DNA binding, DNA looping, assembly of paired-end complex and DNA cleavage (Liu et al., 2007) .
We found that Metnase enhances non-homologous end joining and promotes genomic integration of foreign DNA, perhaps via its association with DNA Ligase IV (Lee et al., 2005 , Hromas et al., 2008 . Both the histone methylase and nuclease domains are essential for Metnase-mediated double-strand break (DSB) repair and genomic integration in vivo (Lee et al., 2005) . The SET domain is responsible for dimethylating H3K36 adjacent to induced DNA DSBs, and this dimethylation stabilizes the Ku and MRN complex at the DSB, which explains Metnase enhancement of DSB repair (Fnu et al., 2011) . Metnase is also important for timely restart of stalled replication forks, perhaps by decatenating positively supercoiled DNA in front of the fork (Roman et al., 2007; Williamson, et al., 2008; Wray et al., 2009; De Haro et al., 2010) . Interestingly, although Metnase is only present in primates (Lee et al., 2005; Cordaux et al., 2006) , it functions with the murine NHEJ repair apparatus when overexpressed in these non-primate cells, and enhances DNA repair in that organism as well .
Replication fork arrest upon DNA damage is regulated by a cascade of phosphorylation events, initiated upon damage sensing by ATM/ATR, with effectors of fork arrest and DNA repair as targets (Zhou and Elledge, 2000) . As Metnase is a novel component of the DSB repair pathway, we hypothesized that it was also regulated by phosphorylation. Therefore, in this study, we explored the phosphorylation of Metnase upon DNA damage and the origin and consequences of that phosphorylation. We discovered that Metnase is phosphorylated on Ser495 (S495) in response to DNA damage, mainly by Chk1, and dephosphorylated by PP2A. A Ser495Ala (S495A) mutant of Metnase was not phosphorylated by Chk1, and had decreased localization to induced DSBs. This decreased DSB association resulted in decreased H3K36me2 formation near the DSB. In addition, the S495A mutant demonstrated decreased religation capacity of an induced DSB. Interestingly, the S495A mutant had an increased ability to restart stalled replication forks. Thus, Chk1 phosphorylation differentiates between the ability of Metnase to repair DSBs and its ability to enhance replication fork recovery. These data reveal an epistatic link between Chk1 damage sensing and DSB repair through stimulation of the DSB repair function of Metnase. They also shed light on the mechanism by which Chk1 mediates two of its major functions, cell cycle (replication) arrest and DNA repair.
Results
Metnase is phosphorylated on S495 in response to DNA damage Because protein phosphorylation has key roles in regulating DNA replication and repair, we investigated whether Metnase, which has roles in both of these processes, is also phosphorylated. Metnase possesses several sites that could potentially be phosphorylated by kinases known to be active in DNA replication and repair. There are two ATM/ATR consensus sites, 50-DIDPTQ-56 and 639-FVESQ-643 (Kim et al., 1999) . In addition, the sequence surrounding S495 (489-YDNRRRSA-496) overlaps a Chk1/2 consensus target phosphorylation site (LxRxxS) with a p21-activated kinase (PAK) consensus site (Brzeska et al., 1997; O'Neill et al., 2002) , and it is also a possible site for protein kinase C (PKC). Each of these kinases can be activated by DNA damage, and are candidates for phosphorylation of Metnase (Canman et al., 1998; Matsuoka et al., 1998; Roig and Traugh, 1999) . We first tested whether Metnase is phosphorylated in vivo after DNA damage. Inorganic 32 P was indeed incorporated into Metnase in vivo, and this incorporation was markedly enhanced following DNA damage with ionizing radiation (IR) (Figure 1a ). Incorporation of 32 P into Metnase was due to protein phosphorylation, because most of the incorporated 32 P was removed following incubation with l-protein phosphatase ( Figure 1a ). There is a baseline level of Metnase phosphorylation observed in the absence of IR treatment ( Figure 1a , lane 1), which may be due to phosphorylation of Metnase in response to endogenous DNA damage during cell cycle progression (Kastan, 2001; Wilkes et al., 2003) .
To further dissect Metnase phosphorylation, we carried out two-dimensional phosphopeptide mapping analysis of Metnase after IR. Human embryonic kidney 293 (HEK-293) cells overexpressing Flag-Metnase were metabolically labeled with 32 P-orthophosphate, Metnase was immunoprecipitated using anti-Flag, and the immunoprecipitate was analyzed by 2D gel electrophoresis for peptide(s) carrying 32 P. A single phosphopeptide was identified, and whose presence was found to be significantly enhanced following IR (Figure 1b) . To determine phosphorylation site of Metnase in vivo, Metnase was immunoprecipitated from HEK-293 cells overexpressing Flag-Metnase following IR (20 Gy), and analyzed for phosphopeptide(s) using nano-LC/MS/ MS. This analysis showed only one phosphopeptide, which perfectly matched the S495 domain (Figure 1b,  Supplementary Figure 1 ). To examine whether S495 was the only Metnase phosphorylation site, we generated a S495A mutant of Metnase, and expressed it in HEK-293 cells. The S495A Metnase species showed no phosphorylation in vivo when cells were incubated with 32 P and irradiated ( Figure 1c ). This result was consistent with the 2D gel mapping result, which identified a single phosphopeptide following IR treatment.
Phosphorylation of Metnase S495 by Chk1 S495 occurs within a Chk1, Chk2 and PAK consensus phosphorylation sequence (RxxS), as mentioned above. This site is in the DDE-like transposase nuclease domain, although not in the active site (Figure 2a,  Supplementary Figure 2) . We virtually modeled the three-dimensional location of the S495 site within the Metnase tertiary structure (Supplementary Figure 2) . Our previous structural analysis indicated that the Metnase DNA-binding site positioned the DNA strand across the groove where S495 is located, as the DNA approaches the catalytic triad at the active site (Goodwin et al., 2010, Supplementary Figure 2) . Our model indicates that the region is quite flexible, but that phosphorylation could affect the mobility of this region. This in turn may influence DNA positioning relative to the catalytic triad. Thus, this model suggests that the nuclease function of Metnase could be altered by phosphorylation (see below). We examined whether Chk1, Chk2 or PAK2 could phosphorylate the S495 of Metnase using in vitro kinase assays. Pure recombinant Chk1, Chk2 and PAK2 were incubated with pure recombinant Metnase nuclease fragment (Roman et al., 2007) and 32 P-ATP. Proteins were segregated by denaturing gel electrophoresis, and phosphorylated species were detected by autoradiography. Although both Chk2 and PAK2 phosphorylated Metnase to some extent, Chk1 had at least 8-fold greater activity for Metnase than Chk2 and PAK2 (Figure 2b) . We then generated an antibody against phosphorylated S495 of Metnase (anti-pS495), and tested whether it could recognize phosphorylated Metnase (Figure 2c ). V5-tagged Metnase was immunoprecipitated and treated with l-phosphatase or untreated. Anti-pS495 recognized only the untreated, phosphorylated form of Metnase (Figure 2c ). We then examined the ability of several kinase inhibitors to block the phosphorylation of Metnase ( Figure 2d ). As cell populations have a fraction of phosphorylated Metnase present constitutively, as noted above, we analyzed the effect of kinase inhibitors without inducing DNA damage. The Chk1 inhibitor UCN-01 significantly decreased the presence of phosphorylated Metnase. The pan-kinase inhibitor staurosporine was partially inhibitory, but the other kinase inhibitors, including the PKC inhibitor G109203X, had little or no effect.
As PP2A has been reported to antagonize the effects of Chk1 (Leung-Pineda et al., 2006) , we tested whether the PP1/PP2A inhibitor okadaic acid could reverse the dephosphorylation of Metnase (Figure 2e ). We found that okadaic acid did indeed increase the phosphorylation of Metnase, and overcame the decrease in phosphorylation seen with UCN-01. However, okadaic acid worked only when it was added prior to UCN-01, indicating that there is dynamic phosphorylation and dephosphorylation of Metnase within the cell.
Becasue kinase inhibitors can have off-target effects, it was possible that the decrease in S495 phosphorylation seen with UCN-01 could have been due to its minor activity against Chk2. Therefore, we used previously characterized short hairpin RNA to repress the expression of Chk1, and examined whether this altered the level of pS495. We found that even mildly decreasing Chk1 expression nearly completely abrogated Metnase phosphorylation ( Figure 3a) . In like manner, okadaic acid inhibits both PP1 and PP2A. We used short hairpin RNA to repress PP2A specifically, and found that it significantly increased the Metnase phosphorylation (Figure 3b ), indicating that PP2A specifically dephosphorylates Metnase. When PP2A was repressed, the activity of Chk1 was unopposed and Metnase phosphorylation increased.
Metnase phosphorylation regulates replication fork recovery and DNA repair Metnase enhances DNA DSB repair via its histone methylase activity (Fnu et al., 2011) . After a DNA DSB is formed, Metnase associates with chromatin adjacent to the DSB and dimethylates H3K36. This dimethylation stabilizes NHEJ components, such as the Ku complex, at the DSB and increases the religation of the DSB (Fnu et al., 2011) . We isolated chromatin before and after IR and hydroxyurea (HU) to measure its association with wild-type (wt) and S495A mutant Metnase by western blot analysis ( Figure 4a ). We found that IR-induced DNA damage modestly increased the amount of total Metnase associated with chromatin In vitro phosphorylation of pure recombinant Metnase by pure recombinant Chk1, Chk2 and PAK2 kinases, with and without their inhibitors (UCN-01, CKII and staurosporin, respectively), is shown. (c) The anti-phospho-Ser495 (anti-pS495) antibody recognizes phosphorylated Metnase. V5-tagged wt Metnase was immunoprecipitated from HEK-293T cells using the V5 tag, and treated with 400U l-protein phosphatase in the presence or absence of phosphatase inhibitors (as described in Materials and methods). The immunoprecipitate was analyzed for the presence of phosphorylated S495 using specific anti-sera. The loss of signal upon phosphatase treatment implies the direct phosphorylation of Metnase at S495. (d) Metnase phosphorylation in vivo in the presence of kinase inhibitors, listed above the panel. Below the panel are the types of kinases inhibited. The Chk1 inhibitor, and to a lesser extent the pan-kinase inhibitor, block the phosphorylation of S495 on Metnase as detected by western blot analysis using antipSer495 after immunoprecipitation of V5-tagged wt Metnase. The samples are as follows: (1) no treatment; (2) UCN-01 (Chk1 inhibitor); (3) CKII (Chk2 inhibitor); staurosporine (pan-kinase inhibitor, including PAK2 and Chk1); PD90859 (ERK2 inhibitor); and GF109203X (PKC inhibitor). (e) The PP2A inhibitor okadaic acid reverses the ability of the Chk1 kinase inhibitor UCN-01 to inhibit phosphorylation of Metnase S495. After immunoprecipitation of V5-tagged wt Metnase from cells pretreated with UCN-01, okadaic acid or both, pS495 was detected using western blot analysis. Okadaic acid was effective only when it was added prior to UCN-01.
(1.3-fold) 1 h after IR. However, the S495A Metnase had little constitutive association with chromatin and no increase after IR (Figure 4a ). It should be noted that the S495A species was expressed at lower levels than wt Metnase (Figure 4a , right panel), but not to the same extent as the decrease in the association of the S495A with chromatin. Interestingly, phosphorylated Metnase showed a marked increase (3.4-fold) in chromatin association after IR, but there was a 1.4-fold decrease after HU (Figure 4b , right panel). This prompted us to test whether HU induces Metnase phosphorylation. Tagged Metnase was immunoprecipitated and then assessed for phosphorylation using anti-pS495. After 18 h of HU exposure, there was a modest increase (1.2-fold) in the phosphorylation of Metnase (Figure 4c) . Thus, IR stimulates phosphorylation of Metnase to a greater extent than HU, and IR also stimulates the association of phosphorylated Metnase with chromatin, whereas HU decreases this association. It should be noted that the endogenous levels of phosphorylated Metnase protein are lower in the IR experiments because cells were incubated at room temperature during the mock and test radiation exposure.
We next asked whether the S495A Metnase species co-immunoprecipitates with histone H3, the target of the histone methylase function of Metnase (Fnu et al., 2011) . We found that the S495A Metnase interacted significantly less with histone H3 than the wt Metnase (Figure 4d ). We then used our previously described HT1904 cells in chromatin immunoprecipitation (ChIP) experiments to measure the relative concentration and rate at which wt versus S495A Metnase associated with a single ISce-I-induced DSB (Fnu et al., 2011) . As shown previously, wt Metnase was rapidly recruited to the induced DSB, but the S495A mutant showed little or no recruitment to the DSB (Figure 4e ). Thus, Metnase is phosphorylated in response to DSB damage and this modification is important for its recruitment to DSBs.
We then examined the role of the S495 phosphorylation on the activities of Metnase in HEK-293T cells, which do not express Metnase by virtue of their transformation with T antigen (Williamson et al., 2008) . Wt Metnase enhances restart of stalled forks after replication stress from HU in these cells (De Haro et al., 2010) . Recovery of replication forks after HU exposure can be measured by the appearance of immunofluorescent bromodeoxyuridine (BrdU) foci, which designate regions of active incorporation of nucleotides (Petermann et al., 2010) . We found that the cells expressing S495A Metnase had significantly more BrdU foci per cell than cells expressing wt Metnase after exposure and release from HU for 15 min (Figure 5a ). We found that 13% of 293T cells transduced with S495A mutant Metnase, but none expressing wt Metnase, had >10 foci/cell (Figure 5b ). Thus, Metnase phosphorylation decreases its ability to enhance recovery of replication forks from stress, consistent with the known function of Chk1.
We then assessed whether the S495A mutant could dimethylate H3K36, because it appeared that this mutant was defective in associating with an induced DSB. Metnase is universally expressed in human cells, except those transformed by T antigen, for reasons that are not clear. However, such cells serve as a useful model to measure some Metnase functions. We found that in HEK-293T cells, the S495A mutant had a decreased ability to dimethylate H3K36 compared with wt Metnase by western blot analysis (Figure 6a ). ChIP analysis corroborated this result as the S495A mutant was unable to induce H3K36me2 at a single DSB in HT1904 cells (Figure 6b, top panel) . H3K36me2 promotes DSB repair by NHEJ, and the H3K36 methylation defect of the S495A mutant also conferred a DSB repair defect as measured by real-time PCR using primers flanking the I-SceI DSB site (Figure 6b, bottom  panel) .
The three-dimensional model of the Metnase S495 site (Supplementary Figure 2) indicates that this region is quite flexible, suggesting that S495 phosphorylation could affect the structure of this region, and thereby influence DNA positioning and nucleolytic activity. To test this, we compared the nucleolytic digestion of a pseudo-Y structure by purified wt Metnase, which occurs as a mixture of phosphorylated and nonphosphorylated forms, and fully nonphosphorylated S495A mutant Metnase. The S495A mutant protein showed greater overall nucleolytic activity and produced a greater overall variety of cleavage products compared with wt Metnase (Figure 6c) . Thus, S495 phosphorylation appears to decrease Metnase nuclease activity, but increase cleavage specificity.
Finally, we previously reported that Metnase interacts with Topo IIa and enhances its decatenation ability (Williamson et al., 2008 , Wray et al., 2009 . Therefore, we examined whether the S495A mutant affected the ability of Metnase to enhance Topo IIa-mediated decatenation. We found that pure recombinant S495A protein was still able to promote Topo IIa decatenation (Supplementary Figure 3) .
Discussion
Much of DNA replication and repair is regulated by effector protein phosphorylation (Bartek and Lukas, 2003) . Metnase is a recently described histone methylase and nuclease with roles in both replication and repair (Lee et al. 2005; De Haro et al., 2010) . Since many of the effectors of these functions are regulated by phosphorylation, we examined whether Metnase was also regulated by phosphorylation. We used 32 P labeling of intracellular Metnase, 2D phosphopeptide isolation and mass spectroscopy to show that Metnase is phosphorylated on S495. Two lines of evidence demonstrate that the S495 is the only Metnase phosphorylation site. First, mutating this site completely blocked incorporation of 32 P orthophosphate into Metnase after DNA damage induction. Second, only one labeled phosphopeptide was seen in the 2D gel after DNA damage.
S495 lies within a Chk1, Chk2 and PAK2 consensus target sequence. Although each of these kinases phosphorylated Metnase in vitro, Chk1 was far more active. Inhibiting Chk1 with UCN-01 or repressing it with small interfering RNA markedly decreased phosphorylation of Metnase, whereas other specific kinase inhibitors had only minimal effect. Even a modest knockdown of Chk1 dramatically reduced Metnase phosphorylation, probably due to counter-balancing phosphatases that remain active (Leung-Pineda et al., 2006) . Consistent with this, we found that the PP2A phosphatase dephosphorylates Metnase. Metnase may be undergoing a continuous, dynamic cycle of phosphorylation-dephosphorylation by Chk1 and PP2A. With even modest decreases in Chk1 activity, there is substantial dephosphorylation of Metnase apparently due to unbalanced PP2A activity. A basal level of phosphorylated Metnase was observed, which is not surprising because Chk1 is active even in unperturbed cells, likely in response to endogenous replication stress and DNA damage (Bartek and Lukas, 2003) .
Metnase S495 also lies within a reasonable PKC target. However, we do not consider PKC to be a major kinase for Metnase for several reasons. First, Metnase is a nuclear protein, and PKC is mainly cytoplasmic. Second, the PKC inhibitor GF109203X had little effect on Metnase phosphorylation. Third, although PKC has crucial roles in apoptotic decisions upon DNA DSB damage, it has no known role in the actual repair of DNA DSBs (Reyland, 2009) . Our data indicate that the most important kinase responsible for Metnase phosphorylation is Chk1, although there is some redundancy. This redundancy could be important in activating the DNA repair activity of Metnase, as there may be situations where DNA is damaged, and Chk1 is not activated, but Chk2 and PAK2 are. Nonetheless, these data place Metnase within the epistatic cascade initiated by DNA damage, whether from exogenous or endogenous sources. These data also implicate a role for PP2A in replication fork recovery (either directly at forks or indirectly through S-phase checkpoint regulation) as dephosphorylated Metnase appears to be more active in this role. This is consistent with previous reports that PP2A is required for deactivating Chk1 by dephosphorylation of S317, and for appropriate metabolism of RPA in the recovery of stalled forks (LeungPineda et al., 2006; Feng et al., 2009) .
The phosphorylation of Metnase S495 inhibits its role in replication fork recovery and stimulates its role in DNA DSB repair. This regulation may reflect changes to the Metnase nuclease activity that has greater activity and lower specificity in the nonphosphorylated state. Although these activity changes could reflect structural changes upon phosphorylation, modeling indicates that S495 is on the exterior surface and phosphorylation of this residue is not expected to cause dramatic structural changes. The altered nuclease activity of unphosphorylated S495A Metnase has several implications. First, the nuclease activity of Metnase could have an important role in replication fork recovery, because this was increased in cells expressing S495A. Compared with wt Metnase, the cleavage pattern of the S495A mutant nuclease more closely resembles FEN-1, cutting close to flap junctions of fork-like structures. Second, it implies that the greater specificity of the wt Metnase nuclease is important for its role in DSB repair, because this function is decreased in the S495A mutant. We have recently reported that Metnase is important for resecting overhangs from incompatible free DNA ends during non-homologous end-joining repair (Beck et al., 2011) . The nuclease activity of phosphorylated Metnase may be important in the processing of incompatible DNA ends. Replication stress induced by HU does not enhance association of phosphorylated Metnase with chromatin, suggesting the possibility that the relaxed substrate specificity of the nonphosphorylated form may be important in processing a variety of structures at stalled forks.
The decrease in cellular H3K36me2 seen with the S495A Metnase species is likely due to the decreased chromatin association of this mutant. Indeed, the reduction in DSB repair seen with the S495A mutant implies that H3K36me2 formation and DSB repair are both enhanced by Metnase phosphorylation, consistent with our previous observation that Metnase-mediated H3K36me2 formation enhances DSB repair (Fnu et al., 2011) . In contrast, our results also suggest that Metnase H3K36 dimethylation activity and chromatin association are not important for the ability of Metnase to enhance replication fork recovery after stress. Our results suggest the following models for Metnase function in response to replication stress and DSB repair. With DSB damage, Chk1 is activated and it phosphorylates Metnase. Phosphorylated Metnase is then recruited to chromatin adjacent to the DSB, and dimethylates H3K36 near the DSB, which stabilizes recruited NHEJ components, such as Ku70 and NBS1, and thereby enhances repair (Wang et al., 2001 , Valerie and Povirk, 2003 , Kim et al., 2005 , Lees-Miller and Meek, 2005 . As the SET domain is not likely to be structurally altered by the S495 phosphorylation, Metnase histone methylation activity remains intact after phosphorylation. Thus, the decrease in H3K36me2 at the DSB region in the S495A species is likely from decreased localization of this mutant Metnase to the chromatin at that site. The ChIP data demonstrating the decreased presence of Metnase at the DSB over the time course of repair of an induced DSB supports this hypothesis. How might Metnase phosphorylation/dephosphorylation regulate replication fork recovery after stress? When Chk1 is activated during replication stress, its canonical role is to halt replication until DNA is repaired by phosphorylating Cdc25a, which leads to its ubiquitinylation and degradation, and subsequent replication arrest (Donzelli and Draetta 2003) . We show here that Chk1-mediated phosphorylation of Metnase is important to maintain replication arrest during the critical period immediately after release from replication stress. It remains unclear how Metnase phosphorylation helps enforce replication arrest; this function, combined with enhanced DSB repair activity, may be an important contributor to the essential roles of Chk1 in inhibiting replication recovery and promoting repair. An alternative, but not mutually exclusive model, is that Metnase promotes replication fork recovery after arrest directly via its nuclease activity. In this role, Metnase may need to be in the dephosphorylated state, as this enhances its activity and reduces specificity toward pseudo-Y and other structures that may arise at stalled forks.
In summary, Metnase phosphorylation by Chk1 distinguishes its activities in repair and replication recovery. Metnase phosphorylation enhances its localization to chromatin, and subsequent H3K36 dimethylation and DSB repair, and it helps maintain replication arrest after release from stress, the classical role for Chk1. These functions are significant for the cell, because it would be detrimental to promote replication fork recovery before DNA damage is repaired as this would result in significant genomic instability or cell death. Our data define Metnase as a novel Chk1 effector, mediating important downstream functions in the Chk1 cascade.
Materials and methods
Cell culture, proteins and antibodies Human HEK-293 and HEK-293T cells expressing wt and mutant Metnase were established as previously described (Williamson et al., 2008) . Cells were grown in Dulbecco's Modified Eagle Medium (Hyclone, Fisher Scientific, Pittsburgh, PA, USA) supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA, USA) and antibioticantimycotic reagent (penicillin G, 10 units/ml; streptomycin, 10 mg/ml; and amphotericin B, 0.25 mg/ml) (Invitrogen, Carlsbad, CA, USA). Purified His-Chk1, GST-Chk2 and GST-PAK2 kinases were obtained from Signal Chem (Richmond, BC, Canada). The following antibodies were used: FLAG, actin (Sigma, St Louis, MO, USA); PP2A (Millipore, Billerica, MA, USA); H3K36me2 (Abcam, Cambridge, MA, USA); Chk1, Chk2, PAK2 and BrdU (Cell Signaling, Danvers, MA, USA); V5 (Invitrogen); phosphorylated S495 Metnase (pS495, custom-made, ProSci Inc, Poway, CA, USA). Control and Metnase-specific small interfering RNAs were used as described previously to manipulate Metnase levels (Lee et al., 2006; Fnu et al., 2011) .
Preparation of cell lysates and immunoblot analysis Cells (1 Â 10 5 ) were collected, washed with PBS and lysed in a buffer containing 25 mM HEPES (pH 7.5), 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5% Triton X-100, 20 mM b-glycerolphosphate, 1 mM sodium vanadate, 1 mM DTT and protease inhibitor cocktails (Sigma). Cell lysates (50 mg) were loaded onto a SDS-PAGE and, following gel electrophoresis, proteins were transferred to a polyvinylidene fluoride membrane (Millipore) and immunoblotted with primary antibody followed by peroxidase-coupled secondary antibody (Amersham, Piscataway, NJ, USA) and an enhanced chemiluminescence (Amersham) reaction prior to visualization on Kodak-o-mat film.
In vivo orthophosphate labeling HEK-293 cells overexpressing Flag-Metnase were incubated with 1 mCi of 32 P-orthophosphoric acid for 1 h. Following IR treatment (20 Gy), cells were further incubated for 1 h prior to harvest. Cell extracts (500 mg) were mixed with agaroseconjugated Flag-antibody beads for 1 h for immunoprecipitation of Flag-Metnase. Samples were analyzed by 10% SDS-PAGE, dried and exposed to an X-ray film.
Phosphopeptide mapping using nano-LC/MS/MS Coomassie blue-stained gel pieces were placed in Eppendorf centrifuge tubes. The gel pieces were immersed in 100 ml of 50% 0.1 M ammonium bicarbonate and 50% acetonitrile (by volume) to completely cover the gel pieces. Samples were then incubated at 37 1C for 30 min. After incubation, the reagent was withdrawn and discarded. The gel pieces were dehydrated with 100 ml of pure acetonitrile for approximately 5 min, and excess acetonitrile was decanted. The gel pieces were rehydrated with 100 ml of 10 mM DTT and incubated at 55 1C for 45 min for reduction. The reduction solution was removed and 100 ml of 55 mM iodoacetamide (freshly made) was added to the gel pieces and incubated for 30 min at 37 1C for alkylation. The gel pieces were dehydrated with 100 ml of pure acetonitrile for approximately 5 min. The excess acetonitrile was decanted and dried under vacuum for 15 min. The gel pieces were rehydrated with a trypsin solution (Promega, Madison, WI, USA, V5280, 0.1-0.5 mg) and incubated overnight at 37 1C. Following digestion, peptides were extracted with 0.1% trifluoroacetic acid for 30 min at 37 1C. Tryptic digests (10 ml) were injected onto a 75 mm Â 5 cm C-18 reverse-phase column, and peptides were eluted with a gradient from 5-45% acetonitrile developed over 30 min at a flow rate of 250 nl/min using an Agilent 1100 series nano pump (Agilent, Santa Clara, CA, USA) (Firulli et al., 2004) . The column was interfaced with a LTQ ion trap mass spectrometer (Thermo Fisher Scientific, Pittsburgh, PA, USA), and data were collected in the data-dependent neutral loss MS3 mode. Neutral-loss masses were 98 ( þ 1), 49 ( þ 2) and 32.7 ( þ 3). MS/MS and MS/MS/MS spectra were searched against the IPI human protein database using the SEQUEST algorithm (Sandia National Laboratory, Albuquerque, NM, USA).
Kinase and phosphatase assays For the in vitro kinase assays, 100 ng of each purified kinase (Chk1, Chk2 or PAK2) was incubated with 200 ng of pure recombinant Metnase nuclease fragment (aa 433-671) in kinase buffer (25 mM MOPS, 12.5 mM a-glycerol-phosphate, 25 mM MgCl 2 , 5 mM EGTA, 2 mM EDTA and 0.25 mM DTT) with 250 mM g-32 P-ATP at 30 1C for 30 min. Recombinant Metnase was generated as previously described (Roman et al., 2007) . The reaction was stopped by the addition of loading dye and proteins were separated by 4-12% gradient SDS-PAGE, then the gel was dried and exposed to an X-ray film. Phosphatase reactions were carried out using immunoprecipitated V5-tagged Metnase protein with 400 U/ml l-phosphatase (New England Biolabs, Ipswich, MA, USA) in the presence or absence of phosphatase inhibitors (0.5 M EDTA, 0.5 M NaF and 0.1 M NaVO4). Reactions were carried out at 37 1C for 30 min and proteins were separated by 4-12% gradient SDS-PAGE. Loss of phosphorylation was shown either by exposing the dried gel to an X-ray film or immunoblotting with the antipS495 antibody. This anti-sera had been precleared for reaction with Metnase unphosphorylated peptide. Kinase inhibition was carried out in vivo by incubating HEK-293 cells with various inhibitors for 1 h, immunoprecipitating the tagged Metnase and then blotting for the presence of phosphorylated S495 Metnase using the anti-p-ser495 antibody. Concentrations used were UCN-01 10 mM, staurosporine 50 mM, CKII 20 mM, PD90859 10 mM and GF10920 3 Â 10 mM, all for 1 h. For phosphatase assays, okadaic acid, a PP1 and 2A inhibitor, was incubated for 1 h at 10 mM.
Chk1 and PP2A knockdown HEK-293T cells stably overexpressing wt Metnase were transiently transfected with short hairpin RNA against Chk1 and PP2A (SABiosciences, Frederick, MD, USA) according to the manufacturer's instructions. Forty-eight hours after transfection, cells were harvested and protein lysates were prepared. Wt Metnase was immunoprecipitated and immunoblotted with anti-pSer495 to determine the level of phosphorylation.
Nuclease assays
Wt Metnase and the S495A mutant proteins were isolated as previously described (Roman et al., 2007) . Nuclease activity of these proteins were carried out by incubation with g-P 32 radiolabeled pseudo-Y structures and autoradiography after separation of the cleaved products by urea denaturing gel electrophoresis as described (Roman et al., 2007) .
BrdU immunofluorescence
HEK-293T cells stably expressing either wt Metnase or the S495A mutant, or stably transfected with the empty vector control, were seeded onto coverslips and allowed to adhere for 6 h. After this time, 10 mM HU was added for 18 h. The HU media was removed, cells were rinsed with PBS and fresh media containing 0.03 mg/ml BrdU was added (according to Petermann et al., 2010 , with BrdU substituted for IdU). BrdU incorporation was stopped after 15 min, then cells were fixed and processed for immunostaining using a BrdU-specific antibody (Cell Signaling) according to the manufacturer's instructions. Images were collected using a Zeiss LSM-510 confocal microscope (Zeiss, Thornwood, NY, USA). Fivehundred cells were counted in each condition from at least three slides.
ChIP and real-time PCR ChIP analysis for the presence of wt and mutant Metnase, and H3K36me2, at the chromatin region adjacent to an induced DSB, and DSB repair using real-time PCR was performed as previously described (Weinmann et al., 2001 , Weinmann and Farnham, 2002 , Fnu et al., 2011 . Briefly, HT1904 cells containing a single allele ISce-I site in a puromycin-resistant gene were transiently transfected with empty control vector (pcDNA3.1) or the Metnase expression vectors (pcDNA3.1-Metnase and pcDNA3.1-S495A). These cells were then infected with high-titer adenovirus expressing ISce-I to induce a DSB in the puromycin-resistant gene and cells were harvested at various time points for ChIP analysis of H3K36me2, or wt or S495A mutant Metnase recruitment, or DSB repair. Each experiment was performed twice in triplicate. S.e.m. is calculated and shown, as well as Student's t-test for significance. All ChIP experimental values were obtained by real-time PCR normalized to the input DNA using amplification of glyceraldehyde-3-phosphate dehydrogenase.
Assessment of chromatin-bound Metnase species
Immunoblot analysis of chromatin-bound Metnase was carried out as previously described (Lee et al., 2006) . HEK-293 cells were harvested for 1 h following IR treatment, and treated with cell lysis buffer I (25 mM Hepes, pH 7.5, 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5% Triton X-100, 0.5 mM DTT and 1 mM PMSF) and incubated for 90 min on ice. After centrifugation at 14 000 g for 30 min, pellets were extensively washed four times with cell-lysis buffer I, resuspended in SDS-PAGE loading buffer, and analyzed by a 10% SDS-PAGE. Gels were transferred to polyvinylidene fluoride membrane, probed with anti-FLAG (for Metnase), -Ku70 or -histone H3 antibody (monoclonal mouse IgG; Oncogene Sciences, Cambridge, MA, USA) followed by HRPconjugated secondary antibody. Proteins were visualized by using the ECL system (Amersham).
Modeling of Metnase
The S495 phosphorylation site was modeled in a threedimensional structure of Metnase generated using PyMOL v. 0.99 X-ray crystallographic structures of Metnase (3F2K, 3K9J and 3K9K) and the MOS-1 Mariner transposase (2F7T) (Arnold et al., 2009; Goodwin et al., 2010) . The Metnase structure from the SWISS-MODEL Repository was superimposed in DeepView/SwissPDBViewer v.4.0.1 (http:// spdbv.vital-it.ch/) using the alpha carbons.
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